Skip to main content

Table 4 Patient profile grouping by predialysis potassium and ARB treatment

From: Impact of serum potassium on therapeutic prognosis of maintenance hemodialysis patients on angiotensin receptor antagonists

   Predialysis potassium  
   <4.6 mEq/L ≥4.6 mEq/L  
   ARB(−) ARB(+) ARB(−) ARB(+)  
   Group 1 Group 2 Group 3 Group 4 p value
   (n = 27) (n = 36) (n = 66) (n = 131)  
Age (Years old) 70.2 ± 7.19 72.7 ± 6.54 70.0 ± 6.56 66.8 ± 5.85 0.060
Gender (M to F ratio)   17:10 27:9 37:29 68:63 0.087
Vintage of dialysis (Years) 2.18 ± 2.07 3.67 ± 2.32 6.95 ± 3.31 6.17 ± 3.48 0.002
Diabetes   8 18 18 45 0.131
CAD   5 5 8 32 0.166
CHF   3 3 5 7 0.710
Stroke   4 5 4 8 0.230
SBP at the beginning of session (mmHg) 132.9 ± 11.6 153.7 ± 9.62 143.0 ± 9.43 153.0 ± 7.52 <0.001
DBP at the beginning of session (mmHg) 69.6 ± 5.03 73.3 ± 6.00 73.6 ± 6.04 75.3 ± 4.87 0.019
BUN (mg/dL) 59.4 ± 5.15 55.4 ± 5.23 63.7 ± 5.44 65.6 ± 4.58 <0.001
Kt/V   0.87 ± 0.09 0.83 ± 0.12 0.99 ± 0.11 0.99 ± 0.09 <0.001
Alb (g/dL) 3.55 ± 0.22 3.40 ± 0.23 3.62 ± 0.20 3.71 ± 0.14 <0.001
Hb (g/dL) 10.22 ± 0.39 9.75 ± 0.46 10.02 ± 0.34 10.11 ± 0.26 0.016
CRP (mg/dL) 1.45 ± 1.03 1.96 ± 2.09 0.91 ± 0.63 0.69 ± 0.54 0.004
K (mEq/L) 4.2 ± 0.2 4.2 ± 0.2 5.2 ± 0.2 5.2 ± 0.2
Ca (mg/dL) 8.3 ± 0.3 8.5 ± 0.2 8.6 ± 0.3 8.7 ± 0.3 0.027
P (mg/dL) 5.1 ± 0.6 4.6 ± 0.4 5.4 ± 0.4 5.5 ± 0.4 <0.001
TC (mg/dL) 164.5 ± 21.9 142.3 ± 15.6 152.8 ± 17.7 157.9 ± 18.3 0.083
Blood glucose (mg/dL) 131.3 ± 21.8 139.6 ± 25.3 122.9 ± 20.7 118.3 ± 17.3 0.040
AF   4 2 7 8 0.363
Changes of ST–T segment in ECG   6 16 24 55 0.230
HCV infection   2 4 6 6 0.464
ACEI   1 1 7 11 0.442
ARB   0 36 0 131
CCB   14 30 33 109 <0.001
beta-B   4 8 18 58 0.002
VD   12 19 34 92 0.010
Weekly dose of erythropoietin/DW (U/w/kg) 111.5 ± 41.9 146.4 ± 41.4 118.6 ± 45.9 114.6 ± 44.8 0.272
Observational period   2.66 ± 0.81 2.19 ± 0.74 3.40 ± 0.71 3.65 ± 0.66 <0.001
All-cause death   8 24 19 18 <0.001
Cardiovascular death   5 14 11 13 <0.001
  1. CAD coronary artery disease, CHF congestive heart failure, SBP systolic blood pressure, DBP diastolic blood pressure, BUN blood urea nitrogen, Alb albumin, Hb hemoglobin, CRP C-reactive protein, K serum potassium, Ca calcium, P phosphorus, TC total cholesterol, AF atrial fibrillation, HCV hepatitis C virus, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker, beta-B beta receptor blocker, VD vitamin D3, DW dry weight